About
Kodikaz develops gene therapies for treating various cancers using a proprietary Zip-Code™ technology platform, which enables highly specific and efficient delivery of genetic material to target cells without relying on viral delivery methods.
Explore Kodikaz's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.